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Abstract  
Cadmium (Cd) a highly toxic metal is considered to be a multitarget toxicant, principally its accumulates in the liver, kidney 
and hardly get into the brain parenchyma by the brain-barrier system. In this study, Cd (3 mg/kg body weight (b. w.)) was 
subcutaneously administered to rats for 3 weeks, which shows significantly (P<0.05) increase acetylcholinesterase enzyme 
activity, with significant elevation of lipid peroxidation along with significant (P<0.05) decreased in the levels of antioxidants 
and ATPases enzymes in the brain. Oral administration of silibinin (SB) at 80 mg/kg b. w. significantly normalized the 
acetylcholinesterase activity and reduced the levels of lipid peroxidation and also restored the antioxidant and ATPases 
enzymes in the brain when compared to other doses of SB (20 and 40 mg/kg b.w.). From this study we conclude that SB 
improves the changes in acetylcholinesterase, ATPases and oxidative injury by Cd- induced in brain.    
 




     Cadmium (Cd) is a neurotoxic heavy metal, inorganic toxicant 
of great environmental and human health concern. Cd produces 
neurotoxicity with a complex pathology that includes neurological 
dysfunction in adults and children (Shukla and Singhal, 1984; Hart et 
al., 1989), changes in neurochemistry (Gupta et al., 1993; Gutierrez- 
Reyes et al., 1998; Antonio et al., 1999) and behavioral alterations in 
young rats, (Wong and Klaassen, 1982; Holloway and Thor, 1988). 
Experimental studies have reported histopathological damage with 
extensive haemorrhagic lesions, destruction of fibers, edema and 
pyknotic cells in the brain of developing rats (Wong and Klaassen, 
1982; Me´ndez-Armenta et al., 2001) and young rabbits compared 
with adults after Cd exposure (Gabbiani et al., 1967). It has been 
proposed that the age of the animal plays an important role on the 
neurotoxic effects of Cd (Gupta et al., 1993). 
     Brain is highly susceptible to oxidative lipid injury (Lipid 
Peroxidation) (LPO), because of it having high content of 
peroxidizable unsaturated fatty acids, high oxygen consumption per 
unit weight and its poorly developed antioxidative defense 
mechanism and a high content of transition metals like copper and 
iron in several regions (Floyd, 1999: Calabuse et al., 2000). Cd can 
hardly get into the brain parenchyma by the brain-barrier system, i.e. 
the blood-brain and the blood-cerebrospinal fluid (CSF) barriers 
(Takeda et al., 1999).  
     Cd itself is unable to generate free radicals directly because it 
has only one oxidation state, however, indirect generation of both 
radicals and non radicals such as superoxide radical, hydroxyl 
radical, nitric oxide and hydrogen peroxide respectively, which in turn 
leads to a modification in structural integrity of lipids and secondarily 
affects membrane bound enzymes (Acan and Tezcan, 1995: Shukla 
et al., 1996). Several reports shows that Cd induces the LPO and it 
has an inhibitory action on the antioxidant enzymes and membrane 
bound ATPases (Garcia and Corredor, 2003: Carageogiou et al ., 
2004, Pari and Murugavel, 2007). The brain tissues membrane has 
been susceptible to LPO, which can lead to loss of adenosine 
triphosphatases (ATPases) activity and cell dysfunction (Bonting, 
1970: Ohinishi et al., 1982). ATPases are lipid dependent membrane 
bound enzymes that play a key role in the active transport of ions, 
maintenance of cellular homeostasis and also in neurotransmission 
process. Cd alters the activities of enzymes in particularly 
neutralizing the oxidative stress, which can interfere with brain 
metabolism and also contribute to the neurotoxic effect. Cd increase 
acetylcholinesterase activity and decrease total antioxidant status in 
brain of adult male rats (Carageorgiou et al., 2005). 
     Antioxidants are very important in oxidative stress-related 
disorders and it act as therapeutic agents. The antioxidant 
possessing compound can counteract the decrease in ATPase 
activity and the increase in oxidative stress that are induced by cd 
(El-Missiry and Shalaby, 2000). 
     Flavonolignan Silibinin (Fig,1) is a main biologically active 
component of the polyphenolic compound silymarin , which was  
the extract of milk thistle seeds from silybum marianum(L).Silibinin 
acts mainly as an effective antioxidant (Mira et al, 1994: Valenzuela 
and Garrido, 1994: Saller et al , 2001 : Wellington and Adis, 2001) 
and free radical-scavenging activity (Winterbourn,2008). It also 
possess hepatoprotective (Ferenci et al , 1989), anticancer (Deep 
and Agarwal,2007), chemoprotective (Comelli et al , 2007), 
hypocholesterolemic (Hertog et al , 1993: Skottova et al, 1999), 
cardioprotective (Agoston et al , 2001 : Agoston et al , 2003 ) and 
neuroactive and neuroprotective (Wang et al , 2002 : Kittur et al , 
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2002) activities.  
     The protective effect of silibinin on cadmium induced 
neurotoxicity, however, has not been studied. We therefore 
investigated in wistar male rats whether silibinin therapy improves 
the cd induced alterations in acetylcholinesterase,ATPases and 
oxidative stress in brain of experimental rats. 
 
MATERIALS AND METHODS 
Chemicals  
 
     Silibinin, cadmium chloride and other fine chemicals were 
obtained from Sigma – Aldrich, Co. (St. Louis, Mo, USA). All the 
other chemicals were of analytical grade obtained from a local firm 
(India).  
 
Animals and experimental design 
 
     Male wistar rats of initial body weight 180-220g were used in 
this experimental study. The rats were bred in the Central Animal 
House, Rajah Muthiah Medical College, Annamalai University 
(temperature (28 ± 2 °C; natural light-dark cycle). The laboratory 
animal protocol used in this study was approved (Approval No: 610, 
2009) by the Institutional Animal Ethical Committee (IAEC) at 
Annamalai University, Annamalainagar, India. In this experimental 
study, a total of 36 rats were used. The total rats were divided into 
six groups of six rats in each 
. 
Group 1 Control rats (Vehicle treated) 
Group 2 Normal rats orally administrated with Silibinin (80mg/kg 
bw/day) dissolved in 0.1% Dimethyl Sulphoxide 
(DMSO) for 3 weeks. 
Group 3 Normal rats were subcutaneously received Cd as 
cadmium chloride (3mg/kg bw/ day)(Pari and 
Murugavel, 2005) in isotonic saline for 3 weeks. 
Group 4 Rats subcutaneously received Cd (3mg/kg bw/day) 
followed by oral administration of silibinin (20mg/kg 
bw/day) in 0.1% DMSO for 3 weeks. 
Group 5 Rats subcutaneously received Cd (3mg/kg bw/day) 
followed by oral administration of silibinin (40mg/kg 
bw/day) in 0.1% DMSO for 3 weeks. 
Group 6 Rats subcutaneously received Cd (3mg/kg bw/day) 
followed by oral administration of silibinin (80mg/kg 
bw/day) in 0.1% DMSO for 3 weeks. 
     After experimental period (21days), the treated rats were 
fasted overnight and sacrificed by decapitation. Blood was collected 
with anticoagulant and plasma were collected through centrifugation 
at 2000 x g for 20 min. whole brain was immediately dissected out, 
washed in ice-cold saline to remove the blood. The brain tissues 
were homogenized (10%,w/v) in appropriate buffer (pH 7.4) and 
centrifuged (1000 x g for 10 min) and the clear supernatant was used 
for various biochemical assays. 
 
Determination of acetylcholinesterase activity 
 
     Acetylcholinesterase (AchE) activity was determined by using 
acetylthiocholine iodide as a substrate according to the method of 
Ellman et al (1961). AchE hydrolyzes acetylthiocholine iodide into 
thiocholine and butyric acid in plasma and brain tissue samples. The 
thiocholine reacts with 5,5’ – dithiobis (2-nitrobenzoic acid) to form 5-
thio-2-nitrobenzoic acid and yellow colour developed was measured 
in UV-spectrophotometer at 412nm. 
 
Estimation of LPO and protein carbonyl contents. 
 
     LPO in brain was determined by measuring the levels of 
thiobarbituric acid reactive substances (TBARS) and lipid 
hydroperoxides (LOOH) by the method of Niehaus and Samuelsson 
(1968) and Jiang et al (1992),respectively. The level of protein 
carbonyl content in brain tissue homogenate was determined by the 
method of Levine et al (1990). 
 
Determination of antioxidant activities. 
 
     The levels of reduced glutathione (GSH) in the brain was 
estimated by spectrophotometric method based on the reaction with 
Ellman’s reagent (19.8mg DTNB in 100ml of 0.1% sodium citrate) 
according to Moron et al (1979). The total sulphdryl groups (TSH) 
levels was determined after the reaction with 5,5’-dithiobis (2-
nitrobenzoic acid) using the method of Ellman (1959). The activities 
of superoxide dismutase (SOD)(Kakkar et al., 1984), Catalase 
(CAT)(Sinta, 1972), glutathione peroxidase (GPx)(Rotuck et al., 
1973) and glutathione-S-transferase (GST)(Habig et al., 1974) were 
also measured in brain tissue homogenate by spectrophotometrically. 
The protein concentrations were also measured in brain tissue 
homogenate by the method of Lowry et al (1951). 
 
Determination of ATPases activities 
 
     Total ATPase activity in brain tissue homogenate was 
measured by the method of Evans (1969). The ATPase activity in 
0.1ml aliquot of the tissue homogenates were measured in a final 
volume of 2ml, which containing 0.1ml of 0.1M Tris-HCl (pH 7.4), 
0.1ml of 0.1M NaCl, 0.1ml of 0.1M MgCl2,1.5ml of 0.1M KCl, 0.1ml of 
1mM EDTA and 0.1ml of 0.01M ATP. The reaction was arrested 
after 20min by the addition of 1ml of 10% TCA and then centrifuged 
(1500 x g for 10 min), and the liberated inorganic phosphorus (Pi) 
was estimated in the protein free supernatant. The liberated Pi was 
estimated according to the method of Fiske and Subbarow (1925). 
     The activity of Na+/K+-dependent ATPase was determined by 
the method of Bonting, (1970). In this assay, 0.2ml of  brain tissue 
homogenate was added to the mixture containing 1ml of 184mM 
Tris-HCl buffer (pH 7.5), 0.2ml of 50mM MgSO4, 0.2ml of 50mM KCL, 
2ml of 600mM NaCl, 0.2ml of 1mM EDTA and 0.2ml of 10mM ATP 
and incubated for 15min at 37ºc. The reaction was stopped by the 
addition of 1ml of ice-cold 10%TCA. Then the amount of Pi liberated 
was estimated in protein-free supernatant at 412nm. The activity of 
Ca2+-ATPase was assayed according to the method of Hjertan and 
Pan (1983). In brief, 0.1 ml of tissue homogenate was added to 
mixture containing 0.1 ml 0f 125 mM Tris-HCl buffer (pH 8), 0.1 ml of 
50 mM CaCl2 and 0.1 ml of 10mM ATP. The contents were 
incubated at 37˚C for 15 minute. The reaction was then arrested by 
the addition of 0.5 ml of ice cold 10% TCA and centrifuged. The 
amount of Pi liberated was estimated in supernatant. The activity of 
Mg2+ - ATPase was assayed by the method of Ohinishi et al. (1982). 
The incubation mixture contained 0.1 ml of 375 mM Tris-HCl buffer 
(pH 7.6), 0.1 ml of 25 mM MgCl2, 0.1 ml of 10 mM ATP, 0.1 ml of 10 
mM ATP, 0.1 ml water and 0.1 ml of tissue homogenate. The 
contents were incubated for 15 minute at 37˚C and the reaction was 
arrested by adding 0.5 ml of 10 % TCA. The liberated Pi was then 
estimated in protein free supernatant. The activities of these ATPase 
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enzymes in tissue homogenate were expressed as µg Pi 




     All data’s are expressed as mean ± SD of number of 
experiments (n=6). The statistical significance was evaluated by one-
way analysis of variance (ANOVA) using SPSS version 11.5 (SPSS, 
Cary, NC, USA), and the individual comparison were obtained by 
Duncans’ Multiple Range Test (DMRT). Values were considered 




     To determine whether the Silibinin (SB) has beneficial effect 
in Cd induced oxidative injury in brain, we performed this study with 
a fixed dose of SB (80 mg/kg body weight). 
 
Levels acetylcholinesterase activities 
 
     Fig. 2 indicates the activity of AchE in plasma and brain of 
control and experimental rats. The activities of AchE in brain and 
plasma was significantly (P<0.05) decreased in Cd intoxicated rats 
whereas in the oral administration of SB (80 mg/kg body weight) 
significantly (P<0.05) reversed to near normal.
 
 
Fig 2. Changes in the activities of acetylcholinesterase (AchE) in plasma (A) and brain (B) of control and experimental rats. ATCI: acetyl thiocholine iodide; CON: control; 
SB: silibinin; Cd: cadmium. Values are mean ± SD for 6 rats in each group. a-c In each row, means with different superscript letter differ significantly at p<0.05 (DMRT).  
 
  
Levels of LPO, protein carbonyl contents and GSH 
 
     The levels of LPO products (TBARS and LOOH) and protein 
carbonyl contents were significantly (P<0.05) increased, while the 
level of GSH is significantly (P<0.05) decreased in brain of control 
and experimental rats (Table. 1). After oral administration of SB (80 
mg/kg body weight) to Cd intoxicated rats, the elevated levels  of 
TBARS, LOOH and protein carbonyl contents were significantly 
(P<0.05) decreased with significant (P<0.05) increase in the level of 
GSH when compared with Cd alone treated group.
 
Table 1. Changes in the levels of LPO markers, protein carbonyl contents and GSH in brain of control and experimental rats 
 
Parameters Control Normal + SB (80 mg/kg) Normal +  Cd (3 mg/kg) Cd (3 mg/kg) + 
SB (80 mg/kg) 
TBARS (µmol/g tissue) 13.05 ± 0.96a 12.02 ± 0.93a 21.48 ± 3.06b 15.96 ± 1.59c 
LOOH (mmol/g tissue) 1.02 ± 0.14a 0.96 ± 0.05a 1.95 ± 0.34b 1.26 ± 0.07c 
Protein Carbonyl Contents (nmol/mg 
protein) 
3.97 ± 0.54a 3.41 ± 0.56a 8.39 ± 0.84b 4.68 ± 0.07c 
GSH (µg/mg protein) 3.76 ± 0.23a 3.82 ± 0.21a 1.33 ± 0.18b 2.94 ± 0.43c 










































Antioxidant and ATPases activities  
 
     The Fig 3 demonstrates the changes in the antioxidant 
enzymes activity in brain of control and experimental rats. A 
significant (P<0.05) decrease in the activities of SOD, CAT, GPx and 
GST were observed in Cd intoxicated rats on comparison with 
control rats. Oral administration of SB (80 mg/kg body weight) 
significantly (P<0.05) reverse the antioxidant activities to near normal.     
The data in table 2 demonstrate the activity of ATPase enzymes 
(Na+/K+-ATPase, Ca2+-ATPase and Mg2+-ATPase) in brain of control 
and experimental rats. Treatment with SB (80 mg/kg body weight) 
significantly (P<0.05) increased the activities of ATPases enzymes in 




















Fig 3. Changes in the activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione-S-transferase (GST) in brain of control and 
experimental rats 
CON: control; SB: silibinin; Cd: cadmium. The activities of the enzymes are expressed as follows: SOD - One unit of enzyme activity was taken as the enzyme reaction, which gave 
50% inhibition of nitroblue tetrazolium reduction in one minute/mg protein; CAT - µmoles of H2O2 consumed/min/mg protein; GPx - µg of glutathione consumed/min/mg protein; 
GST- µmoles of 1-chloro2,4-dinitrobenzene- GSH conjugate formed/min/mg protein. Values are mean ± SD for 6 rats in each group.  a-c In each row, means with different 
superscript letter differ significantly at p<0.05 (DMRT).   
 
Table 2. Changes in the activities of adenosine triphosphatase (ATPase) enzymes in brain of control and experimental rats
Groups Control Normal +SB (80 mg/kg) Normal + Cd (3 mg/kg) Cd (3 mg/kg) + SB (80 
mg/kg) 
Total ATPases (µg Pi 
liberated/min/mg protein) 
1.55 ± 0.14a 1.59 ± 0.15a 0.98 ± 0.07b 1.38 ± 0.15c 
Na+/K+- ATPase (µg Pi 
liberated/min/mg protein) 
0.40 ± 0.03a 0.42 ± 0.01a 0.23 ± 0.01b 0.35 ± 0.04c 
Ca2+ - ATPase (µg Pi 
liberated/min/mg protein) 
0.55 ± 0.09a 0.58 ± 0.05a 0.29 ± 0.03b 0.48 ± 0.04c 
Mg2+ - ATPase (µg Pi 
liberated/min/mg protein) 
0.43 ± 0.04a 0.44 ± 0.04a 0.21 ± 0.01b 0.35 ± 0.05c 
Discussion 
 
     Numerous studies demonstrate that changes in the 
antioxidant system and impairment of sodium and potassium 
transport are essential factors involved in the brain tissue 
disturbance in various kinds of oxidative injury in the central nervous 
system (Jenner, 1998: Slyshenkov et al., 2002: Pari and Murugavel, 
2007). The potency of Cd as a neurotoxin has been demonstrated in 
both invitro and in vivo studies (Antonio et al., 2003: Mendez-
Armenta et al., 2003: Monroe and Halvorsen, 2006: Pari and 
Murugavel, 2007). 
     Oxidative stress affects numerous cellular components, such 
as DNA, lipids and proteins, through oxidation reactions. Recent 
studies have shown that cadmium produce reactive oxygen species, 
resulting in an increased lipid peroxidation depletion of sulfhydryls, 
altered calcium homeostasis and finally DNA damage (Mendez-
Armenta et al., 2003: Pari and Murugavel, 2007). 
     Oxidative stress refers to the cytopathalogical consequences 
of an imbalance between the production of free radicals in the brain 
and the ability of the cell to defend against them (Zhu et al., 2006). 
Cd can penetrate the blood brain barrier and accumulate into the 
brain which is easily susceptible to oxidative lipid injuries, named 
lipid peroxidation (LPO) (Gutierrez-Reyes et al., 1998). In this study, 
the elevation of LPO and increased formation of protein carbonyls 
with reduced levels of TSH in Cd intoxicated rat brain might be due 
to over production of free radicals and LPO end products, where 
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     “leads to oxidative modification of proteins.” Chelation of Cd 
reduces the oxidative stress, reverses the antioxidant level and 
glutathione metabolizing enzymes activities due to the presence of 
hydroxyl groups in SB and it react with free radicals (Sun and 
Oberley, 1996).  
     Changes in the activities of membrane bound ATPases are 
estimated to exert a significant impact on the physiological and 
metabolic functions of cellular membrane. Previous studies showed 
that Cd decreased the membrane fluidity and increased LPO by 
binding to phospholipids (Shaikh et al., 1999), and target various 
intracellular proteins and membrane transporters at their cytoplasmic 
side by binding to their reactive SH or COO groups (Stacey and 
Klaassen, 1999).  
     The maintenance of the cation gradient by the ATPase 
enzymes is essential and fundamental for the regulation of cell 
growth and differentiation, which are critical for the normal 
functioning of the cells. The changes in ionic concentrations can 
bring about diverse types of cell injury, which ultimately lead to cell 
death (Kane, 1996). Our data indicate a remarkable diminution in the 
activities of membrane bound ATPases in the tissues. These findings 
corroborate with the previous studies in which Cd has been shown to 
inhibit the activities of Na+/K+ ATPase, Mg2+ ATPase and Ca2+ 
ATPase (Torre et al., 2000; Garcia and Corredor, 2003; 
Carageorgiou et al., 2004).   
     Administration of SB depleted the elevation of LPO in the 
tissues and sustained the activities of membrane bound enzymes. 
The preservation of cellular membrane integrity by SB depends on 
their antioxidant properties that neutralize the oxidative reactions.  
The lipophilic nature of SB favours its passage through the 
membrane, and can accommodate in the lipid bilayer, thereby 
protecting the radical attack and maintaining the normal physiology 
of the membrane.  In addition, SB reduced the accumulation of Cd 
and improved the levels of endogenous antioxidants involved in 
membrane protection (Van Acker et al., 1995), which in turn reduced 
the Cd induced alterations in membrane bound enzymes as well as 
ionic gradients within the cell. 
     In conclusion, our studies shows that the SB may improve the 
changes in membrane bound enzymes such as acetylcholinesterase, 
ATPases and oxidative injuries induced by the Cd in brain. Its action 
may be due to the presence of hydroxyl groups in SB and it react 
with free radicals. Further studies are also required to study of the 
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